ClinicalTrials.Veeva

Menu

Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay

University of Copenhagen logo

University of Copenhagen

Status

Completed

Conditions

Pancreatic Cancer

Treatments

Dietary Supplement: Oral Impact, Nestlé Health Science

Study type

Interventional

Funder types

Other

Identifiers

NCT01789073
H-1-2012-146

Details and patient eligibility

About

The purpose of this study is to investigate the effect of preoperative immunonutrition on complications and length of hospital stay in patients with pancreatic cancer undergoing elective surgery.

Enrollment

35 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men and women referred to treatment at Surgical Gastroenterology Clinic C, Ward 2122 for pancreatic cancer
  • Age > 18 years.

Exclusion criteria

  • Age < 18 years
  • Pregnant and lactating women
  • Persons who cannot understand and/or speak Danish
  • Renal dysfunction
  • Milk allergy
  • Participants are excluded if elective surgery is not indicated after all

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 2 patient groups

Oral Impact, Nestlé Health Science
Experimental group
Description:
Oral Impact-arm receives the intervention the last 7 days prior to surgery
Treatment:
Dietary Supplement: Oral Impact, Nestlé Health Science
Control
No Intervention group
Description:
The control-arm receives no intervention but is treated according to the standard procedures

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems